第五代头孢洛林酯和头孢比罗酯钠药物的临床研究和不良反应研究进展
Clinical Research and Adverse Reactions Progress of the Fifth-generation Ceftaroline Fosamil and Ceftobiprole Medocaril Sodium
李诗媛 1陈雨晞 1贺彤1
作者信息
摘要
第五代头孢菌素类药物头孢洛林酯、头孢比罗酯钠抗菌谱较广,疗效佳,耐受性较好,安全性高,具有较高的临床价值,值得推广应用.本文通过对相关文献进行分析,归纳头孢洛林酯和头孢比罗酯钠的现有临床数据,就两种药物的作用机制、不良反应、耐药性研究及其在患者中的运用效果等方面进行综述.
Abstract
The fifth-generation ceftaroline fosamil and ceftobiprole medocaril sodium exhibit excellent safety,good tolerance,good efficacy,and a broad antibacterial range.So they have high clinical value.Additionally,they are worthy of promotion and application.This article reviews the mechanism of action,adverse reactions,drug resistance studies,and application effects of ceftaroline fosamil and ceftobiprole medocaril sodium by summarizing the available clinical data based on the analysis of pertinent literature.
关键词
头孢洛林酯/头孢比罗酯钠/耐药性/临床研究/不良反应Key words
ceftaroline fosamil/ceftobiprole medocaril sodium/drug resistance/clinical research/adverse reaction引用本文复制引用
出版年
2024
NETL
NSTL
万方数据